MEDDIC

MEDDIC is a sales opportunity qualification methodology used in complex B2B (large deals, long cycles, multiple decision makers). Its name is an acronym of the six elements a sales rep needs to understand before investing time in an opportunity: Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain and Champion. The core idea is simple: an opportunity only moves forward if you have a solid answer to each of the six questions.

Unlike quick prospecting frameworks, MEDDIC is not meant to decide whether someone is a good lead, but to diagnose how qualified an already open opportunity is and where the gaps are that could make it fall through. It is a pipeline management tool as much as a selling tool: when a team records these six fields in its CRM, the sales forecast becomes far more reliable because every opportunity has evidence behind it. Operationally, MEDDIC usually lives as fields and checklists inside the sales process that Sellium structures on Salesforce, alongside activity tracking and pipeline stages.

What each letter means

MEDDIC breaks down into six criteria the sales rep must be able to answer with concrete data, not assumptions. Metrics are the numbers that quantify the value of the project for the customer: how much it saves, how much additional revenue it brings in, how many hours it frees up. Without metrics, there is no business case to justify the purchase. The economic buyer is the person with real budget authority to approve the spend, who is almost never the technical contact you first start talking to. The decision criteria are the conditions (technical, commercial, support) the customer will use to choose between vendors. The decision process describes the formal steps, approvals and timelines up to signature. Identifying the pain means naming the business problem that hurts enough to justify the change. And the champion is the person inside the customer who wants you to win, has internal influence and sells for you when you are not in the room.

Why it matters in a complex sale

In high-ticket B2B deals, many opportunities are not lost to a competitor: they are lost to "no decision." MEDDIC tackles exactly that by forcing the rep to validate that there is real pain, a buyer with money and a known decision process before logging the opportunity as advanced. This improves the win rate because opportunities with no future are ruled out early, and it improves forecast accuracy because the pipeline stops being inflated with phantom deals. A sales manager can look at an opportunity and ask "who is the economic buyer?" or "did you confirm the decision process?", and if there is no answer, the opportunity should not be in the stage where it sits.

The variants: MEDDPICC and MEDDICC

Over the years, the framework has been extended. MEDDICC adds a second C for Competition, so you do not ignore who you are up against. MEDDPICC also adds the P for Paper Process: the legal, procurement and signature path that often stalls a deal already won on the commercial side. In Latin America this P is especially useful because corporate procurement processes, tenders and committee approvals tend to take longer than the rep estimates.

How it is used in practice

MEDDIC is not a call script; it is a diagnostic grid that gets reviewed in every pipeline meeting. The usual approach is to:

• Turn each criterion into a field on the opportunity in the CRM (with statuses such as "confirmed," "assumed" or "empty").
• Score the opportunity: the more criteria validated, the higher the qualification.
• Use the gaps as an action plan: if the champion is missing, the next activity is building one; if the economic buyer is missing, getting that meeting.
• Review it in RevOps meetings or the weekly forecast, not as bureaucracy but as a traffic light for deal health.

A concrete example (Argentina)

A software company sells a management solution to a consumer goods distributor in Buenos Aires. The rep talks to the IT manager (enthusiastic, but with no budget). Applying MEDDIC, the rep discovers that: the metric is reducing stockouts by 15%; the economic buyer is the commercial director, whom the rep has not met yet; the decision criteria include integration with its current system; the decision process goes through a committee that meets once a month; the pain is losing sales to shortages; and a champion with clout is missing. The diagnosis is clear: the opportunity looked hot, but without access to the economic buyer or a champion, it is not ready for the forecast. The plan: have the IT manager (a champion in the making) secure the meeting with the commercial director.

Common mistakes

The most frequent mistake is confusing a friendly contact with a champion: someone who answers your emails does not necessarily fight for you internally. Another is assuming the first person you talk to is the economic buyer. It is also common to mark criteria as "confirmed" without real evidence, which inflates the pipeline all over again. And to apply MEDDIC as a form filled out at the end instead of a guide that steers the discovery throughout the cycle.

MEDDIC vs. BANT (its natural counterpart)

MEDDIC is often compared with BANT, an older and lighter framework. The key difference is scope and when it is used.

They are not mutually exclusive: many teams qualify the lead with BANT at first contact and, once it becomes a real opportunity, go deeper with MEDDIC.